Skip to content
value.today

Ember LifeSciences, Inc.

Total raised
$32 M
1 round on record
Latest round
$32 M
Jun 2025
First round on record
Jun 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ember LifeSciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$32 MNo. 1$10 to $50 million

Ember LifeSciences, Inc.: Raise no. 1, Jun 2025

Investors in this round

50 investors had bought by the notice of Aug 20, 2026: 50 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $50 M offered; $18 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ann Marie Hyllengren · Executive Officer
  • Brian Marie Bejarano · Executive Officer
  • Clayton Marie Alexander · Executive Officer, Director
  • James Marie DeNaut · Director
  • Michael Marie Kaufmann · Director
  • Timothy White · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “0N/A - No finders' fees, nor commissions.”
  • On the amounts: “$50mil in new Series A authorized alongside conversions of $55mil of prior raises SAFEs. Total amount sold includes new Series A capital only (of the $50mil authorized) that has closed as of August 20, 2026.”

Signed by Ann Hyllegren, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 20, 2026. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ember LifeSciences, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (Aug 2026).

    SEC Form D (revenue range) · Aug 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Aug 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Ember LifeSciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 50 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ember LifeSciences, Inc.
NameRoleNamed in
Ann Marie HyllengrenExecutive officerAug 2026
Brian Marie BejaranoExecutive officerAug 2026
Clayton Marie AlexanderExecutive officerAug 2026
Clayton AlexanderExecutive officerMar 2026
Clayton Marie AlexanderDirectorAug 2026
James Marie DeNautDirectorAug 2026
Michael Marie KaufmannDirectorAug 2026
Timothy WhiteDirectorAug 2026
Clayton AlexanderDirectorMar 2026